Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy

Combined hepatocellular-cholangiocarcinoma (HCC-CC) has a reported incidence of less than 5% of primary hepatic malignancies. The treatment approach to this malignancy is undefined. Our objective of this case series is to provide some insight into chemotherapy and/or targeted therapy in this setting...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of gastrointestinal oncology 2017-04, Vol.8 (2), p.347-351
Hauptverfasser:	Rogers, Jane E, Bolonesi, Ryan M, Rashid, Asif, Elsayes, Khaled M, Elbanan, Mohamed G, Law, Lindsey, Kaseb, Ahmed, Shroff, Rachna T
Format:	Artikel
Sprache:	eng
Schlagworte:	Original
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!